DtX 16 Parameter Drug and Alcohol Screening
Standalone point of care device. Single oral fluid sample, 16 substances screened, results in approximately 10 minutes. AS/NZS 4760:2019 compliant. Full digital chain of custody. Sold and deployed independently of HubX. Built for rail, transport, mining, defence, corrections, and other safety-regulated industries.
Broad-spectrum onsite screening from a single oral fluid sample
The EVEDA DtX kit delivers preliminary onsite screening across 16 substances of common workplace concern. One non-invasive saliva collection. Results in approximately 10 minutes. Designed to support workplace, healthcare, and law-enforcement compliance with drug and alcohol policies, and to integrate with confirmatory laboratory testing pathways where operator policy requires it.
Compliant testing
AS/NZS 4760:2019 compliant oral fluid drug detection covering collection protocols, detection thresholds, approved methodologies, and cutoff levels.
Automated image reading
Image-based strip-result capture removes manual transcription variance, locks results to a time-stamped digital record, and produces tamper-resistant documentation.
Cloud reporting and analytics
Secure cloud-based reporting and analytics dashboard. Centralised audit tracking for high-volume deployments. Role-based access. Encrypted at rest and in transit.
Enterprise-grade governance
EVEDA operates under certified management systems including ISO 13485 (medical-device quality), ISO 9001 (quality management), and ISO 27701 (privacy information management).
Rapid operational decisions
Results available in approximately 10 minutes. Supports immediate fitness-for-duty determinations. Reduces downtime compared to lab-only workflows.
Patient management app integration
The DtX kit integrates with an EVEDA patient management app that streamlines testing workflows, record-keeping, chain of custody, and reporting. In-house compliance is workable without lab dependence.
16 substances. Single saliva sample.
One collection swab. Test parameters cover stimulants, opioids and synthetics, depressants, hallucinogens, dissociatives, and alcohol. Detection thresholds align with AS/NZS 4760:2019.
Sample type: oral fluid (saliva). Result time: approximately 10 minutes. Use case: preliminary onsite screening within DAMP (Drug and Alcohol Management Program) frameworks. Designed to integrate with confirmatory laboratory testing pathways where required under operator DAMPs.
Built for operational decision-making
Four feature pillars cover the working-day reality of safety-regulated environments: rapid decisions, accurate result capture, defensible documentation, and certified governance.
1. Rapid operational decision-making
- Results available in approximately 10 minutes
- Supports immediate fitness-for-duty determinations
- Reduces downtime compared to lab-only workflows
- Scalable onsite rapid testing
- High-volume deployment capability
2. Automated accuracy and integrity
- Image-based strip-result reading removes manual transcription variance
- Automatic result capture and digital record
- Tamper-resistant digital documentation
- Image-verified strip reading
3. Full digital chain of custody
- Time-stamped results
- Secure data capture
- Automated audit trail
- Cloud-based reporting and analytics
- Centralised dashboards for audit tracking
- Automated record locking
- Chain of custody documentation functionality
4. Enterprise-grade governance
- ISO 13485 medical-device quality management
- ISO 9001 quality management systems
- ISO 27701 privacy information management
- Cloud secured
- Role-based access controlled
- Encrypted at rest and in transit
Compliant with Rail Safety National Law and AS/NZS 4760:2019
The DtX solution aligns with requirements under the Rail Safety National Law National Regulations (Drug and Alcohol Testing) Amendment Regulations 2024, and the AS/NZS 4760:2019 standard for oral fluid drug detection. The detail below summarises how each obligation maps to DtX capability.
1. Random testing requirements
Operators must conduct annual random testing using risk-based principles (minimum 25 percent in NSW context). DtX supports this through scalable onsite rapid testing, high-volume deployment capability, and centralised reporting dashboards for audit tracking.
2. Oral fluid analysis confirmation
Regulation 28(2)(b)(iiia) now explicitly references "an oral fluid analysis confirming the presence of a drug". DtX aligns through AS/NZS 4760:2019 compliant oral fluid screening, is designed to integrate with confirmatory laboratory testing pathways where required under operator DAMPs, and produces digitised preliminary result documentation.
3. Sample integrity and anti-tampering
The regulations address failure to provide samples, tampering with samples, and alteration of drug concentration prior to testing. DtX risk controls include image-verified strip reading, time-stamped digital capture, automated record locking, secure cloud audit trail, and chain of custody documentation functionality.
Standards compliance: AS/NZS 4760:2019
The DtX 16 parameter kit adheres to AS/NZS 4760:2019 for oral fluid drug detection, covering:
- Collection protocols
- Detection thresholds
- Approved methodologies
- Cutoff levels
Data security and privacy
The EVEDA platform underpinning DtX is:
- Cloud secured
- Role-based access controlled
- Encrypted
- ISO 27701 privacy managed
This supports operator obligations regarding confidential worker data handling, audit defensibility, and secure regulatory reporting.
Safety-regulated industries that already screen by policy
DtX is built for environments where workplace fitness-for-duty is a legal, contractual, or regulatory obligation, and where lab-only workflows cost too much operational time. The capability is the same across sectors; the workflow integration is tailored per industry.
Rail
Onsite, AS/NZS 4760:2019 compliant testing that meets Rail Safety National Law obligations. Scalable to high-volume random testing programmes. Digital audit defensibility for DAMP reporting.
Mining and resources
Onsite screening at remote and FIFO sites. Rapid, non-invasive collection. Centralised reporting across multiple deployment locations. Integrates with existing workplace health programmes.
Defence
Fitness-for-duty screening at training, posting, and operational tempo points. Time-stamped digital chain of custody. Encrypted reporting suitable for restricted environments.
Corrections (prisons and correctional facilities)
Screening for a population with elevated substance-use prevalence in an environment with constrained lab access. Onsite, secure, dignified collection. Full audit trail.
Transport and logistics
Driver, operator, and contractor screening at depots and dispatch points. Rapid result turn-around supports same-shift decisions. Aligns with operator DAMPs.
Healthcare and law enforcement
Workplace and contracted-testing scenarios where rapid preliminary screening informs onward clinical or legal pathways. Designed to integrate with confirmatory laboratory testing where required.
Common questions
What does DtX screen for?
A 16-panel oral fluid drug and alcohol screen.
How long does it take?
Results in approximately 10 minutes.
Is it standards-compliant?
Designed around AS/NZS 4760:2019 for oral fluid drug testing.
Is there a chain of custody?
Yes, a digital chain of custody, with automated image reading and cloud reporting.
Who is it for?
Safety-regulated industries, rail, mining, defence, transport, corrections and law enforcement.
How does it report?
Cloud reporting with enterprise-grade governance and patient-management integration.